DBA - Management Information Systems - 2005, University of Sarasota
An Investigation into the Relationship of Enterprise Architecture, Strategic Planning and Information Technology Investments in Twelve Government Agencies; A Qualitative and Quantitative Approach
The dissertation explored relationships between the Enterprise Architecture Management Maturity Model, Strategy Planning and Performance Measures and Information Technology Investment Management in twelve federal agencies. The research sought to uncover existing relationships though the use of qualitative analysis followed by quantitative analysis of 12 federal agencies. The research is important since technology spend and use is growing we also have a critical need to effectively use resources and align with strategic objectives. Complex organizations need to modernize and streamline technology purchases as part of the overall strategy. In general, this study showed, through qualitative analysis that a significant number of relationships potentially exist. Further, it shows that many were contradictory and, when quantifiably assessed, they were not generally statistically significant. The results of this study show that minimal relationships exist between enterprise architecture, strategic planning/performance measures and/or information technology investments.
SIGMIS-CPR 2011 (May 19, 2011; San Antonio, TX)
“Do Companies Look for Education, Certifications or Experience: A Quantitative Analysis (a overview of the published paper)”
University degrees give a foundation education that can have long reaching application for both personal and professional purposes. However, will a degree lead to an information technology job, in today's competitive market place, for top rated IT company? This study will address education and experience (in years) requirements and whether a professional certification is required for job vacancies in “Information Technology” as advertised by the top eleven firms among the Computerworlds Best 100 Places to Work in IT 2010. The findings suggest that in those job vacancy postings less than one percent of the openings required a Masters. Though, bachelor’s degrees are required for only 70 percent of the jobs while the remaining 11 percent required a bachelors or equivalent; 3 percent Associates and the final 15 percent did not specify any degree requirements.
Title of Book: Strategic Management: Concepts and Cases
Author: Dr. Fred David
Date of Publication: 12-31-11; Copyright 2013
Case Abstract for Bristol Meyers Squibb
Bristol Meyers Squibb (BMY) is a comprehensive strategic management case that includes the company’s year-end 2010 financial statements, organizational chart, competitor information and more. The case time setting is the year 2011. Sufficient internal and external data are provided to enable students to evaluate current strategies and recommend a three-year strategic plan for the company. Headquartered in New York, New York, BMY’s common stock is publicly traded under the ticker symbol BMY.
Headquartered in New York City, Bristol-Myers Squibb is a huge pharmaceutical firm with such blockbuster cardiovascular drugs as Plavix and Avapro for hypertension. BMY also produces antipsychotic medication Abilify and HIV treatments Reyataz and Sustiva. BMY also has excellent products in immunoscience, metabolics, neuroscience, oncology, and virology. BMY has 12 manufacturing plants worldwide and conducts research and development in four countries, sells its products globally; the US accounts for two thirds of BMY’s sales.
Case Abstract for Eli Lilly and Company
Eli Lilly is a comprehensive strategic management case that includes the company’s year-end 2010 financial statements, organizational chart, competitor information and more. The case time setting is the year 2011. Sufficient internal and external data are provided to enable students to evaluate current strategies and recommend a three-year strategic plan for the company. Headquartered in Indianapolis, Indiana, Eli Lilly’s common stock is publicly traded under the ticker symbol LLY.
Headquartered in Indianapolis, Indiana, Eli Lilly is well known for its popular antidepressant drug, Prozac. Eli Lilly produces and markets scores of other medicines for a wide variety of ailments, including its top-selling drug Zyprexa, a neurological therapy for treating schizophrenia and bipolar disorder. Zyprexa however lost patent exclusivity in major markets in October 2011 and generic options quickly dominated that market. Eli Lilly has other top drugs that include Cymbalta (depression), cancer treatments Gemzar and Alimta, and endocrinology (hormone-related) products such as Humalog insulin and osteoporosis medication Evista. Eli Lilly also makes cardiovascular therapies and anti-infective agents, as well as animal health products. The company sells its products in about 140 countries.